| Bioactivity | Crinecerfont (SSR-125543) hydrochloride is a potent, orally active, non-peptide CRF1 receptor antagonist. Crinecerfont can be used for Classic congenital adrenal hyperplasia (CAH) research[1]. |
| Target | IC50: CRF1 receptor |
| Name | Crinecerfont hydrochloride |
| CAS | 321839-75-2 |
| Formula | C27H29Cl2FN2OS |
| Molar Mass | 519.50 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtalyst). |
Crinecerfont hydrochloride
CAS: 321839-75-2 F: C27H29Cl2FN2OS W: 519.50
Crinecerfont (SSR-125543) hydrochloride is a potent, orally active, non-peptide CRF1 receptor antagonist. Crinecerfont c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.